You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API CIMETIDINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CIMETIDINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Prestige Brands Holdings, Inc. TAGAMET cimetidine 52183-223 CELLULOSE, MICROCRYSTALLINE
Prestige Brands Holdings, Inc. TAGAMET cimetidine 52183-223 FD&C BLUE NO. 1 ALUMINUM LAKE
Prestige Brands Holdings, Inc. TAGAMET cimetidine 52183-223 HYPROMELLOSES
Prestige Brands Holdings, Inc. TAGAMET cimetidine 52183-223 MAGNESIUM STEARATE
Prestige Brands Holdings, Inc. TAGAMET cimetidine 52183-223 POLYETHYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing CIMETIDINE

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA, Inc. cimetidine 0093-8192 CARNAUBA WAX
Teva Pharmaceuticals USA, Inc. cimetidine 0093-8192 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA, Inc. cimetidine 0093-8192 D&C YELLOW NO. 10 ALUMINUM LAKE
Teva Pharmaceuticals USA, Inc. cimetidine 0093-8192 FD&C BLUE NO. 1 ALUMINUM LAKE
Teva Pharmaceuticals USA, Inc. cimetidine 0093-8192 FD&C YELLOW NO. 6
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for CIMETIDINE

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: BLUE 1

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 42090

Excipient focus: CI 47005

Excipient focus: CI 77891

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: KI5

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MENTHOL

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: ORANGE

Excipient focus: PEG-20 SORBITAN OLEATE

Excipient focus: POLOXAMER 188

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: PVP

Excipient focus: SACCHARIN SODIUM

Excipient focus: SODIUM ALGINATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SOYBEAN LECITHIN

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: VANILLIN

Excipient focus: WATER

Excipient focus: YELLOW 10

Excipient focus: YELLOW 6

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links